CIK 0001824893 · Non-accelerated filer<br>Smaller reporting company
Surrozen, Inc./DE
Sign in to watch- Ticker
- SRZN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 301374889
- Phone
- 650-475-2820
- Business address
- 171 OYSTER POINT BLVD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Consonance-HFW Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 54 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-14 | Rothenberg Mace Director | Grant or award · Option (right to buy) | +1,333 | 1,333 | ||
| 2025-05-14 | Lin Shao-Lee Director | Grant or award · Option (right to buy) | +1,333 | 1,333 | ||
| 2025-05-14 | WOODHOUSE DAVID J Director | Grant or award · Option (right to buy) | +1,333 | 1,333 | ||
| 2025-05-14 | Berkenblit Anna Director | Grant or award · Option (right to buy) | +1,333 | 1,333 | ||
| 2025-05-01 | Li Yang Exec. Vice President, Research | Grant or award · Option (right to buy) | +26,250 | 26,250 | ||
| 2025-05-01 | Li Yang Exec. Vice President, Research | Grant or award · Restricted Stock Unit | +8,750 | 8,750 | ||
| 2025-05-01 | Williams Charles O CFO and COO | Grant or award · Restricted Stock Unit | +11,250 | 11,250 | ||
| 2025-05-01 | Williams Charles O CFO and COO | Grant or award · Option (right to buy) | +33,750 | 33,750 | ||
| 2025-05-01 | Parker Craig C Chief Executive Officer | Grant or award · Option (right to buy) | +75,000 | 75,000 | ||
| 2025-05-01 | Parker Craig C Chief Executive Officer | Grant or award · Restricted Stock Unit | +25,000 | 25,000 | ||
| 2025-03-26 | Kutzkey Tim Director | Grant or award · Option (right to buy) | +2,666 | 2,666 | ||
| 2025-03-26 | COLUMN GROUP III GP, LP 10% owner | Purchase | +323,886 | $11.60 | $3.8M | 704,332 |
| 2025-03-26 | COLUMN GROUP III GP, LP 10% owner | Purchase | +365,769 | $11.60 | $4.2M | 795,411 |
| 2025-03-26 | COLUMN GROUP III GP, LP 10% owner | Purchase | +344,827 | $11.60 | $4.0M | 344,827 |
| 2025-03-26 | COLUMN GROUP III GP, LP 10% owner | Other disposition · Series A Common Warrants | −90,897 | 0 | ||
| 2025-03-26 | COLUMN GROUP III GP, LP 10% owner | Purchase · Series A Common Warrants | +90,897 | 90,897 | ||
| 2025-03-26 | COLUMN GROUP III GP, LP 10% owner | Other disposition · Series A Common Warrants | −102,651 | 0 | ||
| 2025-03-26 | COLUMN GROUP III GP, LP 10% owner | Purchase · Series A Common Warrants | +102,651 | 102,651 | ||
| 2025-03-26 | COLUMN GROUP III GP, LP 10% owner | Other disposition · Series B Common Warrants | −98,870 | 0 | ||
| 2025-03-26 | COLUMN GROUP III GP, LP 10% owner | Purchase · Series B Common Warrants | +98,870 | 98,870 |
Page 7 of 12 · 237 trades